Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Cooper

Showing results (101-110 of 246) with videos related to

Pageof 25
Sort By:
Diabetes|January 1, 1997
Salt restriction reduces hyperfiltration, renal enlargement, and albuminuria in experimental diabetesT J Allen, M J Waldron, D Casley, et al.
Diabetologia|February 8, 2006
Gemfibrozil decreases atherosclerosis in experimental diabetes in association with a reduction in oxidative stress and inflammationA C Calkin, M E Cooper, K A Jandeleit-Dahm, et al.
The Journal of Diabetic Complications|April 1, 1989
Intermittent diabetic microalbuminuria: association with blood pressure, glycemic control, and protein intakeM E Cooper, R C O'Brien, R M Murray, et al.
Journal of Diabetes and Its Complications|April 1, 1993
Prediction of persistent microalbuminuria in patients with diabetes mellitusL A Bach, R E Gilbert, M E Cooper, et al.
Diabetes Research and Clinical Practice|January 7, 1988
Comparison of early renal dysfunction in type I and type II diabetes: differing associations with blood pressure and glycaemic controlG Jerums, M E Cooper, E Seeman, et al.
Diabetes Care|July 1, 1987
Spectrum of proteinuria in type I and type II diabetesG Jerums, M E Cooper, E Seeman, et al.
The Journal of Diabetic Complications|January 1, 1988
Glomerular filtration rate in early experimental diabetesR C O'Brien, T J Allen, M E Cooper, et al.
Diabetes|October 6, 1997
Role of angiotensin II and bradykinin in experimental diabetic nephropathy. Functional and structural studiesT J Allen, Z Cao, S Youssef, et al.
Kidney International|February 23, 1999
Effect of diabetes and aminoguanidine therapy on renal advanced glycation end-product bindingS Youssef, D T Nguyen, T Soulis, et al.
Diabetes, Obesity & Metabolism|February 28, 2001
Is there a role for endothelin antagonists in diabetic renal disease?K Jandeleit-Dahm, T J Allen, S Youssef, et al.
Pageof 25

Showing results (101-110 of 246) with videos related to

Sort By:
Pageof 25
Diabetes|January 1, 1997
Salt restriction reduces hyperfiltration, renal enlargement, and albuminuria in experimental diabetesT J Allen, M J Waldron, D Casley, et al.
Diabetologia|February 8, 2006
Gemfibrozil decreases atherosclerosis in experimental diabetes in association with a reduction in oxidative stress and inflammationA C Calkin, M E Cooper, K A Jandeleit-Dahm, et al.
The Journal of Diabetic Complications|April 1, 1989
Intermittent diabetic microalbuminuria: association with blood pressure, glycemic control, and protein intakeM E Cooper, R C O'Brien, R M Murray, et al.
Journal of Diabetes and Its Complications|April 1, 1993
Prediction of persistent microalbuminuria in patients with diabetes mellitusL A Bach, R E Gilbert, M E Cooper, et al.
Diabetes Research and Clinical Practice|January 7, 1988
Comparison of early renal dysfunction in type I and type II diabetes: differing associations with blood pressure and glycaemic controlG Jerums, M E Cooper, E Seeman, et al.
Diabetes Care|July 1, 1987
Spectrum of proteinuria in type I and type II diabetesG Jerums, M E Cooper, E Seeman, et al.
The Journal of Diabetic Complications|January 1, 1988
Glomerular filtration rate in early experimental diabetesR C O'Brien, T J Allen, M E Cooper, et al.
Diabetes|October 6, 1997
Role of angiotensin II and bradykinin in experimental diabetic nephropathy. Functional and structural studiesT J Allen, Z Cao, S Youssef, et al.
Kidney International|February 23, 1999
Effect of diabetes and aminoguanidine therapy on renal advanced glycation end-product bindingS Youssef, D T Nguyen, T Soulis, et al.
Diabetes, Obesity & Metabolism|February 28, 2001
Is there a role for endothelin antagonists in diabetic renal disease?K Jandeleit-Dahm, T J Allen, S Youssef, et al.
Pageof 25